Both patients and remitters ask for treatment with Botulinumtoxin A (BTX) with the hope that it will be an effective aid for pain, but little is known regarding if the effect is dose dependent.
The aim of this project is to investigate if injections with BTX in the masseter- and temporal muscle is an efficient treatment in patient with myogenous temporomandibular disorders (TMD) and if the effect of BTX is dose dependent.
Has given a written consent
Diagnose of myalgia, myofacial pain or myofascial pain with referred pain according
Average pain due to NRS ≥ 3 for more than three months
Palpationpain in masseter or temporalis.
Treatment with BTX during the last 12 months
Treatment for orofacial pain within the last 3 months.
Systemic inflammatory diseases (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis)
Widespread pain e.g., fibromyalgia